Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma

Journal of Clinical Oncology

Volumn 24, Issue 28, 2006, Pages 4570-4574

  Gavrilovic, Igor T ^a   Hormigo, Adília ^a   Yahalom, Joachim ^a   DeAngelis, Lisa M ^a   Abrey, Lauren E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; AGE; BRAIN; CENTRAL NERVOUS SYSTEM TUMOR; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DRUG EFFECT; LYMPHOMA; MIDDLE AGED; MORTALITY; RADIATION EXPOSURE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA; MALE; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33750603965     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.6910     Document Type: Article

References (15)

1. Ferreri AJ, Batchelor T, Zucca E, et al: International Collaborative Group against primary CNS lymphomas. J Clin Oncol 21:1649-1650, 2003
2. Neuwelt EA, Guastadisegni PE, Varallyay P, et al: Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery. Am J Neuroradiol 26:258-265, 2005
3. Abrey LE, Yahalom J, DeAngelis LM: Long term survival in primary central nervous system lymphoma (PCNSL). J Clin Oncol 16:859-863, 1998
4. Abrey LE, Yahalom J, DeAngelis LM: Treatment for primary CNS lymphoma: The next step. J Clin Oncol 18:3144-3150, 2000
5. Batchelor T, Carson K, O'Neill A, et al: Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07. J Clin Oncol 21:1044-1049, 2003
6. O'Neill BP, O'Fallon JR, Earle JD, et al: Primary central nervous system non-Hodgkin's lymphoma: Survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 33:663-673, 1995
7. Bessell EM, Graus F, Lopez-Guillermo A, et al: CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 50:457-464, 2001
8. Bessell EM, Lopez-Guillermo A, Villa S, et al: Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: An analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. J Clin Oncol 20:231-236, 2002
9. Nelson DF, Martz KL, Bonner H, et al: Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23:9-17, 1992
10. Abrey LE, Batchelor TT, Ferreri AJM, et al: Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23:5034-5043, 2005
11. Ferreri AJ, Blay JY, Reni M, et al: Prognostic scoring system for primary CNS lymphomas: The International Extranodal Lymphoma Study Group experience. J Clin Oncol 21:266-272, 2003
12. Wu HG, Kim IH, Ha SW, et al: Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas. J Korean Med Sci 14:565-570, 1999
13. O'Brien P, Roos D, Pratt G, et al: Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 18:519-526, 2000
14. Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H, et al: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962: High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma. J Clin Oncol 21:4483-4488, 2003
15. Pels H, Schmidt-Wolf IG, Glasmacher A, et al: Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489-4495, 2003